Physician profile
Tara Berman
NPI 1770849879
$29,111.46
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $100 · 2023: $12K · 2024: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Grant: $1,853 · Travel and Lodging: $1,628 · Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,009.45 |
| Grant | $1,852.67 |
| Travel and Lodging | $1,627.52 |
| Food and Beverage | $521.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $9,181.82 | 2024 | |
| Immunogen, INC. | $8,666.47 | 2023 | Elahere |
| Abbvie INC. | $5,250.00 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $4,752.87 | 2023-2024 | Lynparza |
| Eisai INC. | $1,090.45 | 2022-2023 | |
| Glaxosmithkline, LLC. | $118.13 | 2023 | Jemperli |
| Merck Sharp & Dohme LLC | $51.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.